Relationship between indices of iron status and coronary risk factors including diabetes and the metabolic syndrome in Saudi subjects without overt coronary disease

Journal of Trace Elements in Medicine and Biology

Volumn 21, Issue 4, 2007, Pages 242-254

  Alissa, Eman M ^a   Ahmed, Waqar H ^a,c   Al ama, Nabeel ^a,d   Ferns, Gordon A A ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

^d KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Coronary risk factors; Diabetes mellitus; Ferritin; Metabolic syndrome; Saudi Arabia

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; CHOLESTEROL; FERRITIN; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; IRON; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON INTAKE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK FACTOR; SAUDI ARABIA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 35548999740     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2007.05.002     Document Type: Article

References (31)

1. Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids 36 (2001) S41-S44
2. Fong L., Parathasarathy S., Witztum J., et al. Non-enzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J Lipid Res 28 (1987) 1466-1477
3. Lamb D., Mitchinson M., and Leake D. Transition metal ions within human atherosclerotic lesions can catalyze the oxidation of low density lipoprotein by macrophages. FEBS Lett 374 (1995) 12-16
4. Araujo J., Romano E., Brito B., et al. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 15 (1995) 1172-1180
5. Lee H., Chiu L., Lee T., et al. Dietary iron restriction increases plaque stability in apolipoprotein-e-deficient mice. Biomed Sci 10 5 (2003) 510-517
6. Sullivan J.L. The iron paradigm of IHD. Am Heart J 117 (1989) 1177-1188
7. Sullivan J. Iron and the sex difference in heart disease risk. Lancet 1 (1981) 1293-1294
8. Salonen J., Nyyssonen K., Korpela H., et al. High stored iron levels are associated with excess risk of MI in eastern Finnish men. Circulation 86 (1992) 803-811
9. Klipstein-Grobusch K., Koster J., Grobbee D., et al. Serum ferritin and risk of MI in the elderly: the Rotterdam study. Am J Clin Nutr 69 (1999) 1231-1236
10. Kiechl S., Willeit J., Egger G., et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96 (1997) 3300-3307
11. Morrison H., Semenciw R., and Wigle D. Serum iron and risk of fatal AMI. Epidemiology 5 (1994) 243-246
12. Ascherio A., Willett W., Rimm E., et al. Dietary iron intake and risk of CHD among men. Circulation 89 (1994) 969-974
13. Sempos C., Looker A., and Gillum R. Iron and heart disease: the epidemiologic data. Nutr Rev 54 (1996) 73-84
14. Danesh J., and Appleby P. CHD and iron status. Meta-analysis of prospective studies. Circulation 99 (1999) 852-854
15. Halle M., Konig D., Berg A., et al. Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for CAD. Atherosclerosis 128 (1997) 235-240
16. Lauffer R. Iron stores and the international variation in mortality from CAD. Med Hypotheses 35 (1991) 96-102
17. Cook J., Lipschitz D., Miles L., et al. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 27 (1974) 681-687
18. Koenig W. Inflammation and CHD: an overview. Cardiol Rev 9 (2001) 31-35
19. Fox P., Mukhopadhyay C., and Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human caeruloplasmin. Life Sci 56 (1995) 1749-1758
20. Konijn A., Glickstein H., Vaisman B., et al. The cellular LIP and intracellular ferritin in K562 cells. Blood 94 (1999) 2128-2134
21. Hughes K. Serum ferritin and iron status in the general population of Singapore, 1993 to 1995. Ann Acad Med, Singapore 27 (1998) 507-511
22. Al-Buhairan A., and Oluboyede O. Determination of serum iron, TIBC and serum ferritin in healthy Saudi adults. Ann Saudi Med 21 (2001) 100-103
23. Al-Nozha M., Arafah M., Al-Mazrou Y., et al. CAD in Saudi Arabia. SMJ 25 (2004) 1165-1171
24. Alissa E.M., Bahjri S., Al-ama N., et al. Dietary vitamin A may be a cardiovascular risk factor in a Saudi population. Asia Pac J Clin Nutr 14 (2005) 137-144
25. Al-Nuaim A.R. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years. Int J Cardiol 62 (1997) 227-235
26. Harrison P., and Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochem Biophys Acta 1275 (1996) 161-203
27. Alissa E.M., Bahijri S., and Ferns G. Dietary macronutrient intake of Saudi males and its relationship to classical coronary risk factors. Saudi Med J 26 (2005) 201-207
28. Cook J., Morck T., and Lynch S. The inhibitory effect of soy products on non-heme iron absorption in man. Am J Clin Nutr 34 (1981) 2622-2629
29. Ford E., and Cogswell M. Diabetes and serum ferritin concentration among US adults. Diabetes Care 22 (1999) 1978-1983
30. Milman N., Heitmann B., Lyhne N., et al. Iron status in 1113 Danish men and women aged 35-65 years: relation to dietary and supplemental iron intake. Scand J Nutr 37 (1993) 98-103
31. Pinhas-Hamiel O., Newfield R., Koren I., et al. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 27 (2003) 416-418